CLBX — Cellbxhealth Share News
0.000.00%
Last trade - 00:00- £17.38m
- £15.77m
- £2.86m
Notice of Results
Brief: CelLBxHealth Enters Master Services Agreement With AstraZeneca
MSA with Global Pharmaceutical Company
Collaboration with AdventHealth for two studies
Brief: CelLBxHealth's Board Is Confident In Delivering Revenues For FY 2026 Of At Least £2.1 Million
Brief: CellBxHealth Announces Discontinuation Of FDA License For Parsortix System
Brief: CelLBxHealth Says Co Is Rationalising Operations At Guildford Into One Facility
UK's CelLBxHealth preliminary FY revenue misses its expectations due to deferred contracts
Preliminary Fourth Quarter 2025 Financial Results
Board changes
Holding(s) in Company
PDMR Dealing and ESOT Share Purchase
Brief: Cellbxhealth Says Peter Collins Transitions From Interim CEO To CEO
Result of Retail Offer
Update to Admission of Fundraising Shares
Launch of Retail Offer
Result of Oversubscribed Placing and Subscription
Brief: Cellbxhealth Proposes To Raise £6.8 Million At 1.0 Pence Per Share
Proposed Placing and Subscription